Congratulations to USP's Comfort Ogar on being elected President of the Africa Chapter of the International Society of Pharmacovigilance, an organization that seeks to develop and strengthen pharmacovigilance systems in Africa to promoting the safe and effective use of medicines across the continent. We look forward to engaging with ISoP Africa Chapter and other partners to strengthen the capability of regulators as part of efforts to advance health security. https://ow.ly/k86o50SN4r2
US Pharmacopeia
Pharmaceutical Manufacturing
Rockville, Maryland 160,801 followers
The Standard of Trust.
About us
US Pharmacopeia (USP) is an independent, scientific nonprofit organization that has focused on building trust in the supply of safe, quality medicines since 1820. We are a public health organization that uses rigorous science and public quality standards setting to protect patient safety and improve global health. We are committed to building public trust and confidence in drug therapies to enable people to live longer and healthier, and also work to building trust in dietary supplements and food ingredients. Currently, we are working to strengthen the global supply chain so that the medicines people rely on are available when needed and work as expected. Our Volunteers USP standards are in a continuous process of review and revision based upon new evidence, emerging public health concerns, and public requests for revision. Input from our volunteers, through our Council of Experts and Expert Committees and Panels, is crucial for maintaining our standards and preserving public trust. Our Governing Bodies The USP Convention helps guide our areas of impact – nearly 500 Member Organizations from around the world contribute valuable perspectives, experiences, and expertise from across healthcare and science. In addition to collaborating on critical healthcare and science matters, every five years, Convention Members adopt USP Resolutions and elect USP’s Board of Trustees and the Council of Experts who lead USP’s standards-setting Expert Committees. Visit www.usp.org to learn more.
- Website
-
http://www.usp.org
External link for US Pharmacopeia
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Rockville, Maryland
- Type
- Nonprofit
- Founded
- 1820
- Specialties
- Product Quality–Standards and Verification, Healthcare Information, pharmaceuticals, Medicines quality, medicines safety, substandard medicines, falsified medicines, Medicines Supply Chain, COVID-19 Vaccines, Pharmaceuticals Advanced Manufacturing, and Pharmaceuticals Continuous Manufacturing
Locations
Employees at US Pharmacopeia
-
Shelley Whiddon
Building and implementing strategic initiatives that engage stakeholders and achieve results
-
Scott Bolgiano
Senior Manager, Publishing Technology at USP, the United States Pharmacopeia
-
Melanie V, CIR
Senior Talent Acquisition Partner
-
Stu Kim
Legal Counsel - Pharmaceutical at Catalyst Pharmaceuticals, Inc.
Updates
-
US Pharmacopeia reposted this
#USPScience: This upcoming USP Education webinar will discuss the recommendations for dissolution method development and validation stated in USP General Chapter <1092>. Building on your basic understanding of USP’s approach to dissolution, this course provides a foundation for developing and validating dissolution methods used for batch release and stability testing. These tests are in vitro performance tests for most dosage forms, such as tablets, capsules, suspensions, transdermal systems, suppositories, and other pharmaceutical dosage forms. They are important components of the specifications that establish the strength, quality, purity, and bioavailability of a drug product. Register today ➡: https://ow.ly/JQtE50SMtoG
This content isn’t available here
Access this content and more in the LinkedIn app
-
This week, we had the honor of hosting a delegation of officials from the Ministry of health of Ukraine at our Rockville site. They shared valuable insights into the challenges Ukraine's health systems are facing and we engaged in meaningful discussions on how USP's standards and materials, including the United States Pharmacopeia National Formulary (USP-NF) and the USP Education training library, can help strengthen their medicine quality systems. We look forward to continuing our collaboration in the future! #GlobalHealth #ProudToBeUSP
-
-
-
-
-
2
-
-
“Volunteering with US Pharmacopeia allows me to address the “why” not just the “what” as a QC Chemist working to promote quality and precision across the pharmaceutical manufacturing lifecycle. It’s an opportunity to use my voice as an independent scientific expert and an individual consumer to advance global public health.” 💬 James Salas, USP Expert Volunteer Why should you consider becoming a #USPExpertVolunteer? Hear more from James about how this experience empowers him to make a real difference, in more ways than one, and get inspired to amplify your impact with USP. Join James and apply to serve in our upcoming 2025-2030 cycle: Bit.ly/USPExpertVolunteer
-
To support increased access to quality medicines and vaccines in Africa, we launched #USPAccess4Africa, in collaboration with Africa CDC, African Union Development Agency-NEPAD, the Association of African Universities and the Federation of African Pharmaceutical Manufacturers Associations (FAPMA). The initiative aims to strengthen the pharmaceutical sector in Africa by equipping manufactures with free access to USP Education and the USP-NF, which is the most comprehensive source for medicine quality standards in the world and includes over 5000 quality standards for medicines, active pharmaceutical ingredients, and excipients. Learn more and register: Bit.ly/USPAccess4Africa
-
-
US Pharmacopeia reposted this
Residual host cell proteins (HCPs) are critical quality attributes in biotherapeutics, impacting patient safety and product efficacy. Mass spectrometry (MS) is gaining prominence for its precision in identifying and quantifying individual HCPs, playing a vital role in risk assessment, process optimization, and quality control of biotherapeutic products. This presentation will delve into the USP's initiatives to enhance the quality and consistency of MS-based HCP analysis. Register today! https://ow.ly/zBaA50SIsOy #USPScience
This content isn’t available here
Access this content and more in the LinkedIn app
-
USP's Ingredient Verification Program for Excipients helps verify the quality of excipients—which make up 90% of some finished drug products—by auditing manufacturing sites for conformance with current Good Manufacturing Practices (cGMP,) reviewing quality control and manufacturing (QCM) product documentation and testing product samples in the lab. To learn more about USP's Verification process for excipients, visit: https://ow.ly/N2TB50SmICX
-
-
Producing quality medical devices often depends on both the local manufacturer to comply with good manufacturing practices and meet global quality standards, and on the national regulator to evaluate the safety, efficacy, and quality of the product. Learn how the USAID-funded PQM program is supporting manufacturers & regulators in #Nepal, #Bangladesh and #Pakistan to increase the supply of locally produced, quality-assured medical devices. https://ow.ly/zzlo50SzQpJ
-
What’s behind the unprecedented, persistent drug shortages in the United States and what’s at stake without immediate, collective action? Join us next Wednesday, July 24 at 3 p.m. ET to hear from US Pharmacopeia policy and data experts Carrie Harney and Matt Christian as they dig into the insights from our inaugural Annual Drug Shortages Report. Register now: Bit.ly/USPDrugShortages and invite your colleagues to get the facts on this urgent #PublicHealth crisis, including: 💊 The root causes driving chronic, national shortages. 💊 The devastating impact on patients, families, and providers. 💊 The systemic, complex factors that must be addressed to move forward. #DrugShortage #SupplyChain #NationalHealthSecruity #Webinar
-
-
Reminder that public comment period for Proposed Revisions to USP General Chapter <7> Labeling ends July 31, 2024. Proposed revisions to USP General Chapter <7> Labeling include the removal of ratio expressions of strength in multi-entity drug products, such as Lidocaine and Epinephrine. Learn about this and other proposed revisions here➡️: https://ow.ly/IVTb50SbfqA. Submit your comments by July 31, 2024. #USPScience
-